 |
DNP-Modified autologous tumor vaccine |
|---|---|
| Trade Name | O-Vax |
| Orphan Indication | Ovarian cancer |
| USA Market Approval | USA |
| USA Designation Date | 2000-09-21 00:00:00 |
| Sponsor | AVAX Technologies, Inc.;9200 Indian Creek Parkway, Building 9, Suite 200;Overland Park, Kansas, 66210 |
